JPML Weighs New Opioid MDL As McKinsey Suits Surge
By Jeff Overley · May 27, 2021, 8:23 PM EDT
New multidistrict litigation probably won't streamline dozens of cases accusing McKinsey & Co. of helping drugmakers aggressively market prescription opioids, but squeezing the cases into a long-running opioid MDL might be...
To view the full article, register now.